NanoVibronix Inc

NASDAQ:NAOV   10:18:56 AM EDT
0.88
-0.05 (-5.38%)
Earnings Announcements

Nanovibronix Announces Encouraging Interim Results In Real World Patient Study Of Uroshield

Published: 12/07/2021 13:58 GMT
NanoVibronix Inc (NAOV) - Nanovibronix Announces Encouraging Interim Results in Real World Patient Study of Uroshield.
Nanovibronix Inc- Full Results of Study Are Expected to Be Published in Q2 of 2022.
Nanovibronix - Urine Analysis is Demonstrating Approximate 1 Log Reduction in Bacterial Numbers in Most Patients, a Statistically Significant Outcome.